This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Michigan. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: A Rees Midgley: Innovator in Bioreactor Systems
Introduction
A Rees Midgley is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of bioreactor systems, particularly in the continuous perfusion culturing of mammalian cell lines. His innovative approach has the potential to enhance cell culture techniques in various applications.
Latest Patents
Midgley holds a patent for a bioreactor system designed for continuous perfusion culturing of both anchorage-dependent and anchorage-independent mammalian cell lines. This system simulates in vivo capillary bed conditions by utilizing a growth chamber with a multitubular array of inert, non-degradable, and structurally strong tubes. The invention maintains a constant nutrient gradient along the tubes, ensuring that all areas of the chamber receive fresh medium through convective forces. This method improves oxygen transfer and the removal of toxic wastes, making it a significant advancement in cell culture technology. The preferred embodiment of the invention employs porous inert expanded Teflon tubes with an inner diameter of approximately 1 to 2 millimeters.
Career Highlights
Midgley is affiliated with the University of Michigan, where he continues to contribute to research and innovation in biotechnological applications. His work has garnered attention for its practical implications in the field of cell culture and tissue engineering.
Collaborations
One of his notable collaborators is Craig Reed Halberstadt, with whom he has worked on various projects related to bioreactor systems.
Conclusion
A Rees Midgley's contributions to bioreactor technology exemplify the impact of innovative thinking in the field of biotechnology. His patent for a bioreactor system represents a significant advancement that could enhance the efficiency of mammalian cell culture practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
